Search

everythinglearnresearchcommunity

for

Search:↓

The workshop discussed the role of a protein called calreticulin in health and disease, its potential as a treatment target, and its possible use as a disease marker.

p63 controls Satb1 to help skin develop properly.

Artificial skin grafts face immune rejection, but stem cells may improve future designs.

Engineered extracellular vesicles can improve tissue repair and regeneration.

Understanding tissue regeneration in animals can improve regenerative medicine.

The BUZZ gene is important for root hair growth and overall root structure in the plant Brachypodium distachyon.

For sensitive scalp, treatment is personalized and may include specific medications and hydration, while avoiding stress and irritating products.

Frontal fibrosing alopecia in postmenopausal women can be managed with early treatment using corticosteroids to stop hair loss.

Cyclosporine A slowly changes cell membranes, explaining some of its effects and side effects.

A multi-drug treatment can effectively clear extensive calcinosis in juvenile dermatomyositis.

Intralesional steroid injections can effectively treat calcinosis and ulcers in scleroderma.

Janus kinase inhibitors may effectively treat resistant scalp conditions like folliculitis decalvans and dissecting cellulitis.

Both penicillamine and tiopronin have significant side effects, but trying the alternative drug can be beneficial if the first is not tolerated.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

ICI therapy increases the risk of gastrointestinal and endocrine issues in psoriasis patients.

Early intervention is important for limited systemic sclerosis patients due to higher pain and ulceration risks.

Cyclosporine can cause a unique skin condition called "cyclosporine-induced folliculodystrophy."

Combining ciclosporin and simvastatin can cause severe kidney damage.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Recurrent NICF is a rare skin condition with unclear causes, involving follicle inflammation and crystal deposits.

JAK inhibitors show promise for treating various skin diseases.

The ointment is a safe, effective, and well-tolerated treatment for certain types of psoriasis.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Cutaneous calcinosis can be induced in young animals using certain compounds, but only in specific areas and with high mortality.

Two new IRAK4-inhibitors effectively reduced skin inflammation and immune response markers in healthy volunteers.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.